Acadia Pharmaceuticals Stock Technical Analysis
| ACAD Stock | USD 16.29 0.08 0.49% |
As of the 29th of November, ACADIA Pharmaceuticals owns the market risk adjusted performance of 0.0511, and Coefficient Of Variation of 2974.8. ACADIA Pharmaceuticals technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm ACADIA Pharmaceuticals mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if ACADIA Pharmaceuticals is priced adequately, providing market reflects its prevailing price of 16.29 per share. Given that ACADIA Pharmaceuticals has jensen alpha of (0.12), we suggest you to validate ACADIA Pharmaceuticals's latest market performance to make sure the company can sustain itself at some future date.
ACADIA Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ACADIA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ACADIAACADIA |
ACADIA Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 31.25 | Buy | 20 | Odds |
Most ACADIA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ACADIA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ACADIA Pharmaceuticals, talking to its executives and customers, or listening to ACADIA conference calls.
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ACADIA Pharmaceuticals Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ACADIA Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ACADIA Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for ACADIA Pharmaceuticals. You can use it to identify possible trend reversals for ACADIA Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ACADIA Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ACADIA Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ACADIA Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.01 , which means ACADIA Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 5.67, which is the sum of squared deviations for the predicted ACADIA Pharmaceuticals price change compared to its average price change.About ACADIA Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ACADIA Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ACADIA Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding ACADIA Pharmaceuticals. By analyzing ACADIA Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ACADIA Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ACADIA Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.78 | 0.8 | 2.61 | 2.48 | Days Of Inventory On Hand | 150.28 | 238.26 | 285.89 | 153.81 |
ACADIA Pharmaceuticals November 29, 2024 Technical Indicators
Most technical analysis of ACADIA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ACADIA from various momentum indicators to cycle indicators. When you analyze ACADIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0324 | |||
| Market Risk Adjusted Performance | 0.0511 | |||
| Mean Deviation | 1.72 | |||
| Semi Deviation | 1.95 | |||
| Downside Deviation | 2.07 | |||
| Coefficient Of Variation | 2974.8 | |||
| Standard Deviation | 2.26 | |||
| Variance | 5.09 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0411 | |||
| Maximum Drawdown | 13.74 | |||
| Value At Risk | (3.24) | |||
| Potential Upside | 3.45 | |||
| Downside Variance | 4.27 | |||
| Semi Variance | 3.8 | |||
| Expected Short fall | (1.85) | |||
| Skewness | 0.9125 | |||
| Kurtosis | 2.65 |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |